| 1. |
Jun Hata、Ryu Matsuo、Toshiharu Ninomiya、Masahiro Kamouchi、Takanari Kitazono, Hypercholesterolemia as a risk factor for stroke incidence and recurrence in Japan: findings from the Hisayama Study and Fukuoka Stroke Registry, The 19th International Symposium in Atherosclerosis, 2021.10. |
| 2. |
Matsuo R, Nakamura K, Wakisaka Y, Kitazono T, Ago T , Impact of current smoking on clinical outcomes in patients with acute reperfusion therapy after ischemic stroke., The Joint European Organization and World Stroke Organization Conference 2020 , 2020.11. |
| 3. |
Sakai S, Osaki M, Kimura S, Hidaka M, Arakawa S, Ago T, Matsuo R, Kamouchi M, Kitazono T., Prognosis in Mild or Rapidly Improving Ischemic Stroke Not Treated with Recombinant Tissue Plasminogen Activator: Fukuoka Stroke Registry., International Stroke Conference 2018, 2018.12. |
| 4. |
Shota Sakai, Masato Osaki, Shunsuke Kimura, Masaoki Hidaka, Shuji Arakawa, Tetsuro Ago, Ryu Matsuo, Masahiro Kamouchi, Takanari Kitazono, Prognosis in Mild or Rapidly Improving Ischemic Stroke Not Treated with Recombinant Tissue Plasminogen Activator: Fukuoka Stroke Registry, Asian Pacific Stroke Conference 2017, 2017.10. |
| 5. |
Yoshinobu Wakisaka, Ryu Matsuo, Junya Kuroda, Tetsuro Ago, Masahiro Kamouchi, Takanari Kitazono, Influence of pre-stroke cholinesterase inhibitor treatment on short-term functional outcome in acute ischemic stroke patients with pre-stroke dementia: the Fukuoka Stroke Registry, 8th Korea-Japan Joint Stroke Conference, 2017.10. |
| 6. |
Takehiro Michikawa, Ryu Matuso, Kayo Ueda, Tetsuro Ago, Hiroshi Nitta, Takanari Kitazono, Masahiro Kamouchi, Fukuoka Stroke Registry Investigators, Short-term exposure to fine particulate matter increased hospital admissions for ischaemic stroke in Japan, 29th Annual Scientific Conference of the International Society of Environmental Epidemiology 2017 (ISEE2017), 2017.09. |
| 7. |
Ryu Matsuo, Yuko Yamaguchi, Tomonaga Matsushita, Kenji Fukuda, Fumi Kiyuna, Yoshinobu Wakisaka, Junya Kuroda, Tetsuro Ago, Masahiro Kamouchi, Takanari Kitazono, Impact of onset-to-door time on clinical outcomes in patients with acute ischemic stroke: the Fukuoka Stroke Registry , 3rd European Stroke Organisation Conference (ESOC 2017), 2017.05, Kiyuna F, Wakisaka Y, Kuroda J, Ago T, Kamouchi M, Kitazono T, on behalf of the FSR investigators. . |
| 8. |
Takeshi Yamashita, Hirotsugu Atarashi,, Hiroshi Inoue, Shinichiro Uchiyama, Takanari Kitazono, Wataru Shimizu, Takanori Ikeda, Koichi Kaikita, Masahiro Kamouchi, Koji Fukuda, Hideki Origasa, Hiroaki Shimokawa, EXPAND Study Investigators, Effectiveness and Safety of Rivaroxaban in Patients with Non-Valvular Atrial Fibrillation. -The First Report from the EXPAND Study-, 第81回日本循環器学会学術集会, 2017.03. |
| 9. |
Matsuo Ryu, Yuko Yamaguchi, Masahiro Kamouchi, Hiroshi Sugimori, SHONO YUJI, Tetsuro Ago, Takanari Kitazono, Association between Neurological Symptoms at Stroke Onset and Use of Ambulance – The Fukuoka Stroke Registry, Asian Pacific Stroke Conference (APSC) 2016, 2016.07. |
| 10. |
Yoko Noichi, Matsuo Ryu, Shuji Arakawa, Shinobu Furukawa, Kei Murao, Yuriko Ito, Taisuke Kitamura, Tetsuro Ago, Masahiro Kamouchi, Takanari Kitazono, Informed Consent in a Multicenter Stroke Registry: Fukuoka Stroke Registry (FSR), Asian Pacific Stroke Conference (APSC) 2016, 2016.07. |
| 11. |
Kayo Wakisaka, Takahiro Kuwashiro, Tetsuro Ago, Noriko Makihara, Hitonori. Takaba, Masahiro Yasaka, Masahiro Kamouchi, Yasushi Okada, Takanari Kitazono, Blood Pressure and stroke recurrence after transient ischeamic attack: the Fukuoka Stroke Registry, European Stroke Organisation Conference ESOC 2016, 2016.05. |
| 12. |
Matsuo Ryu, Masahiro Kamouchi, Fumi Kiyuna, Tetsuro Ago, Takanari Kitazono, FSR Investigators, Cardiovascular outcomes in patients with minor ischaemic stroke or high-risk transient ischaemic attack in Japan: the Fukuoka Stroke Registry, European Stroke Organisation Conference ESOC 2016, 2016.05. |
| 13. |
Fumi Kiyuna, Matsuo Ryu, Yoshinobu Wakisaka, Junya Kuroda, Tetsuro Ago, Masahiro Kamouchi, Takanari Kitazono, Association between high-sensitivity CRP at stroke onset and clinical outcomes in patients with small vessel occlusion, European Stroke Organisation Conference ESOC 2016, 2016.05. |
| 14. |
Yoshinobu Wakisaka, Matsuo Ryu, Jun Hata, Junya Kuroda, Tetsuro Ago, Masahiro Kamouchi, Takanari Kitazono, Pre-stroke dementia is associated with poor functional outcome after acute ischemic stroke: the Fukuoka Stroke Registry, International Stroke Conference 2016, 2016.02. |
| 15. |
Takanori Ikeda, Hisao Ogawa, Hirotsugu Atarashi, Hiroshi Inoue, Shinichiro Uchiyama, Takanari Kitazono, Takeshi Yamashita, Wataru Shimizu, Koichi Kaikita, Masahiro Kamouchi, Koji Fukuda, Kunihiko Matsui, Hiroaki Shimokawa, Effectiveness and Safety of Rivaroxaban in Patients with Non-Valvular Atrial Fibrillation. –The Second Report from the EXPAND Study-, 第80回日本循環器学会学術集会, 2016.03. |
| 16. |
Matsuo Ryu, Masahiro Kamouchi, Jun Hata, Yoshinobu Wakisaka, Junya Kuroda, Tetsuro Ago, Takanari Kitazono, FSR investigators, Pioglitazone treatment and long-term post-stroke prognosis in diabetic patients with acute ischemic stroke: the Fukuoka Stroke Registry, Asia Pacific Stroke Conference 2015, 2015.10. |
| 17. |
Ryu Matsuo, Masahiro Kamouchi, Jun Hata, Yoshinobu Wakisaka, Junya Kuroda, Tetsuro Ago, Takanari Kitazono, Association of high-sensitivity C-reactive protein at stroke onset with short-term clinical outcomes after ischemic stroke: the Fukuoka Stroke Registry, European Stroke Organisation Conference 2015, 2015.04. |
| 18. |
Hiromi Ishikawa, Yoshinobu Wakisaka, Noriko Makihara, Tetsuro Ago, Junya Kuroda, Ryu Matsuo, Jun Hata, Jiro Kitayama, Hiroshi Nakane, Masahiro Kamouchi, Takanari Kitazono, Statin pretreatment is associated with initial stroke severity in non-cardioembolic ischemic stroke patients with dyslipidemia: the Fukuoka Stroke Registry, European Stroke Organisation Conference 2015, 2015.04. |
| 19. |
Shinichiro Uchiyama, Hisao Ogawa, Hirotsugu Atarashi, Hiroshi Inoue, Takanari Kitazono, Takanori Ikeda, Koichi Kaikita, Masahiro Kamouchi, Koji Fukuda, Kunihiko Matsui, Hiroaki Shimokawa, EXPAND Study Investigators, Effectiveness of Rivaroxaban for Secondary Prevention on Long-Term Outcome in Patients with Atrial Fibrillation: Results of EXPAND, a Multicenter Cooperative Registry in a Nationwide Cohort, European Stroke Organisation Conference 2015, 2015.04. |
| 20. |
Masaya Kumamoto, Shigeru Fujimoto, Masato Osaki, Takao Ishitsuka,, Tetsuro Ago, Masahiro Kamouchi, Takanari Kitazono, Efficacy of prior antiplatelet treatment in patients with noncardioembolic ischemic stroke or transient ischemic attack, 9th World Stroke Congress, 2014.10. |
| 21. |
Hiroshi Nakane, Jiro Kitayama, Yoji Yoshikawa, Hiromi Ishikawa, Asako Nakamura, Tetsuro Ago, Masahiro Kamouchi, Takanari Kitazono, Clinical features of cerebral venous thrombosis in Japanese patients, 9th World Stroke Congress, 2014.10. |
| 22. |
Kenji Fukuda, Hisashi Kai, Masahiro Kamouchi, Jun Hata, Tetsuro Ago, Tsutomu Imaizumi, Takanari Kitazono, Within-individual day-by-day blood pressure variability during subacute stage predicts functional and long-term survival outcomes in ischemic stroke patients: Fukuoka Stroke Registry, Congress of the European Society of Cardiology 2014, 2014.08, , Masahiro Kamouchi, Jun Hata, Tetsuro Ago, , Takanari Kitazono. . |
| 23. |
Ryu Matsuo, Masahiro Kamouchi, Jun Hata, Yoshinobu Wakisaka, Junya Kuroda, Tetsuro Ago, Takanari Kitazono, Intravenous recombinant tissue plasminogen activator therapy for ischemic stroke patients over 80 years old: a propensity score matched analysis from the Fukuoka Stroke Registry, European Stroke Conference, 2014.05, Ryu Matsuo, Masahiro Kamouchi, Jun Hata, Yoshinobu Wakisaka, Junya Kuroda, Tetsuro Ago, Takanari Kitazono.. |
| 24. |
Masato Osaki, Shigeru Fujimoto, Juro Jinnouchi, Masaya Kumamoto, Tetsuro Ago, T Ishikawa, Masahiro Kamouchi, Takanari Kitazono, Clinical characteristics od DWI false-negative stroke: The Fukuoka Stroke Registry, European Stroke Conference, 2014.05, , , Masaya Kumamoto, Tetsuro Ago, T Ishikawa, Masahiro Kamouchi, Takanari Kitazono. |
| 25. |
Ryu Matsuo, Masahiro Kamouchi, Jun Hata, Yoshinobu Wakisaka, Junya Kuroda, Tetsuro Ago, Takanari Kitazono, Intravenous recombinant tissue plasminogen activator therapy for ischaemic stroke patients over 80 years old: a propensity score matched analysis from the Fukuoka stroke registry, European Stroke Conference, 2014.05. |
| 26. |
M Osaki, S Fujimoto, J Jinnouchi, M Kumamoto, Tetsuro Ago, Masahiro Kamouchi, T Ishitsuka, Takanari Kitazono, Clinical characteristics of diffusion weighted imaging (DWI) false-negative stroke: the Fukuoka stroke registry, European Stroke Conference, 2014.05. |
| 27. |
K Nakamura, Tetsuro Ago, Ryu Matsuo, Junya Kuroda, Yoshinobu Wakisaka, T Isomura, H Awano, K Suzuki, Masahiro Kamouchi, Yutaka Kiyohara, H Ooboshi, Takanari Kitazono, Temporal profile of basic fibroblast growth factor and its clinical implications in ischemic stroke - Research for Biomarkers in Ischemic Stroke (REBIOS) -, Neuroscience, 2013.11. |
| 28. |
Tetsuro Ago, K Nakamura, K Arimura, A Nishimura, N Makihara, Yoshinobu Wakisaka, Junya Kuroda, Masahiro Kamouchi, Takanari Kitazono, The expression of pericyte PDGFRβ is regulated by basic FGF after ischemic stroke., Neuroscience, 2013.11. |
| 29. |
Masahiro Kamouchi, Ryu Matsuo, Tetsuro Ago, Junya Kuroda, T Kuwashiro, H Sugimori, Takanari Kitazono, Efficacy and safety of intravenous thrombolysis with tissue plasminogen activator in elderly patients with acute ischemic stroke; Fukuoka Stroke Registry (FSR) - nested case control study, 第20回 IAGG World Congress of Gerontology and Geriatrics, 2013.06. |
| 30. |
Jun Hata, Toshiharu Ninomiya, Y Hirakawa, M Nagata, N Mukai, S Gotoh, M Fukuhara, F Ikeda, K Shikata, D Yoshida, Masahiro Kamouchi, Takanari Kitazono, Yutaka Kiyohara, Trends in stroke, coronary heart disease, and cardiovascular risk factors during the past half century in a Japanese community: the Hisayama Study, 1961-2009. , European Stroke Conference, 2013.05. |
| 31. |
Yoshikawa Y, Fukuda K, Masahiro Kamouchi, Makihara N, Tachibana M, Kiyuna F, Wada C, Fukushima Y, Takanari Kitazono, The impact of CHADS2 score on short-and long-term outcome after cardioembolic stroke - Fukuoka Stroke Registry (FSR) – , European Stroke Conference, 2013.05. |
